Anebulo Pharmaceuticals Inc (ANEB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.43
• Market Cap: $17.47M
• EPS: $-0.18
• 52-Week High: $3.42
• 52-Week Low: $0.41

Market Sentiment

Anebulo Pharmaceuticals Inc currently has a Bearish sentiment score of -0.24.

About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Lakeway, Texas, dedicated to addressing urgent medical needs in cannabinoid overdose and addiction treatment. With a proprietary drug development platform, Anebulo is advancing a differentiated product pipeline aimed at combating substance use disorders, a critical area of healthcare demand. The company's strategic focus on innovative therapeutics positions it as a potential leader in improving patient ou...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Anebulo Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ANEB pay dividends?

Anebulo Pharmaceuticals Inc (ANEB) does not currently pay a regular dividend.

What is ANEB's market cap?

Anebulo Pharmaceuticals Inc (ANEB) has a market capitalization of $17.47M with a current stock price of $0.43.